Wells Fargo Maintains Overweight on Visteon, Raises Price Target to $139

Benzinga Newsdesk www.benzinga.com Positive 76.3%

Neg 0% Neu 0% Pos 76.3%

Wells Fargo analyst Colin Langan maintains Visteon (NASDAQ:VC) with a Overweight and raises the price target from $125 to $139.